The store will not work correctly when cookies are disabled.
3-chloro-N-(4-phenoxyphenyl)quinoxalin-2-amine
ID: ALA4538930
PubChem CID: 155549395
Max Phase: Preclinical
Molecular Formula: C20H14ClN3O
Molecular Weight: 347.81
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Clc1nc2ccccc2nc1Nc1ccc(Oc2ccccc2)cc1
Standard InChI: InChI=1S/C20H14ClN3O/c21-19-20(24-18-9-5-4-8-17(18)23-19)22-14-10-12-16(13-11-14)25-15-6-2-1-3-7-15/h1-13H,(H,22,24)
Standard InChI Key: KVEXDAUCTWHGSO-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
11.2552 -13.1826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1125 -13.1837 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
12.6827 -11.5232 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.5415 -11.9423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2533 -11.5295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6804 -13.1801 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.5403 -12.7697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1158 -11.5300 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4003 -11.9407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9687 -11.9387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9675 -12.7671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3991 -12.7692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1177 -10.7128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8278 -10.3113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8301 -9.4949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1228 -9.0838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4118 -9.4950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4130 -10.3101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1237 -8.2666 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8319 -7.8587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5390 -8.2695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2466 -7.8624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2479 -7.0443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5357 -6.6351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8309 -7.0446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9 8 1 0
6 12 2 0
12 9 1 0
10 11 1 0
12 2 1 0
10 5 2 0
7 1 1 0
5 4 1 0
1 11 2 0
11 6 1 0
9 3 2 0
4 7 2 0
10 3 1 0
8 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 347.81 | Molecular Weight (Monoisotopic): 347.0825 | AlogP: 5.82 | #Rotatable Bonds: 4 |
Polar Surface Area: 47.04 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 0.77 | CX LogP: 5.66 | CX LogD: 5.66 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.51 | Np Likeness Score: -1.07 |
References
1. (2017) Aryl amine substituted quinoxaline used as anticancer drugs, |